Homologous News and Research

RSS

Study explores differences in the efficiency of COVID-19 vaccine boosters

In a new study, researchers predicted the efficacy of coronavirus disease 2019 (COVID-19) vaccine boosters.

30 Aug 2022

Study reveals impacts of multiple SARS-CoV-2 Wuhan-based vaccinations on the Omicron variant of concern

In a new study, researchers analyzed the influence of multiple shots of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Wuhan strain vaccinations on the Omicron variant.

30 Aug 2022

mRNA COVID boosters are effective against severe Omicron for at least six months

A new study published in the journal JAMA Network Open aimed to analyze the association of the types of vaccine and their combination with the waning of protection against Omicron in residents of Singapore who were aged 30 years and above and had received at least two doses of a COVID vaccine.

30 Aug 2022

What is the stability of SARS-CoV-2 strains in human biological fluids?

In a new study, researchers assessed the stability of ancestral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage in human biological fluids.

24 Aug 2022

Serious health events rare in children after COVID-19 vaccine booster, says CDC study

Researchers published the effects of a homologous booster dose of the BNT162b2 COVID-19 vaccine in children aged five to 11 years.

22 Aug 2022

The neutralizing antibody escape of BA.2.75 in mRNA-vaccinated and BA.1-infected individuals

Investigators analyzed the neutralization escape of the SARS-CoV-2 Omicron BA.2.75 variant.

17 Aug 2022

Superior protection with 'mix-and-match' COVID-19 booster strategy

Researchers discuss the durability and immunogenicity of homologous and heterologous booster regimens.

14 Aug 2022

The neutralizing activity of a panel of 482 human monoclonal antibodies against Omicron BA.4 and BA.5

Researchers demonstrated differential utilization of the B cell germlines and SARS-CoV-2 spike protein epitopes by cross-neutralizing antibodies in infected, vaccinated and individuals with hybrid immunity.

9 Aug 2022

Study reveals key similarities between the nervous system of two early-diverging animal lineages

Neurons, the specialized cells of the nervous system, are possibly the most complicated cell type ever to have evolved. In humans, these cells are capable of processing and transmitting vast sums of information. But how such complicated cells first came about remains a long-standing debate.

9 Aug 2022

Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster

A new study monitored the safety of the second booster dose of SARS-CoV-2 messenger ribonucleic acid vaccination among those ≥50 Years.

2 Aug 2022

CDC study describes safety profile of second mRNA COVID booster

The CDC investigates the safety profile of a fourth dose of mRNA-based COVID-19 vaccines in people aged 50 years and older.

1 Aug 2022

Cross-reactive SARS-CoV-2 antibodies after exposure to avian coronavirus vaccine

Researchers identify SARS-CoV-2 cross-reactive antibodies in poultry farm workers exposed to the avian infectious bronchitis virus.

28 Jul 2022

Study shows SARS-CoV-2 impairs interferon production through NSP2-induced repression of mRNA translation

Researchers discovered a SARS-CoV-2 non-structural protein 2 (NSP2)-mediated mechanism by which it suppresses the production of interferon-beta (IFN-β) in host cells.

27 Jul 2022

The neutralizing antibody response in mRNA vaccinated and boosted healthcare workers against major circulating SARS-CoV-2 Omicron subvariants

Researchers assessed the duration of the neutralizing antibody responses after SARS-CoV-2 mRNA booster vaccination.

27 Jul 2022

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

A new study discusses the development of recombinant vesicular stomatitis virus COVID-19 vaccines.

25 Jul 2022

Booster vaccination counters the severity of Omicron breakthrough infections

Researchers assessed a panel of seven SARS-CoV-2 vaccines currently available globally and in the United States and immunity acquired through the previous infection against all Omicron subvariants.

21 Jul 2022

The clinical, epidemiological, and evolutionary consequences of a potential SARS-CoV-2-related bat virus spillover into humans

A team of scientists from France has recently described the epidemiological and clinical consequences of a bat sarbecovirus infection in humanized mice.

20 Jul 2022

Homologous News and Research

Study explores differences in the efficiency of COVID-19 vaccine boosters

Study reveals impacts of multiple SARS-CoV-2 Wuhan-based vaccinations on the Omicron variant of concern

mRNA COVID boosters are effective against severe Omicron for at least six months

What is the stability of SARS-CoV-2 strains in human biological fluids?

Serious health events rare in children after COVID-19 vaccine booster, says CDC study

The neutralizing antibody escape of BA.2.75 in mRNA-vaccinated and BA.1-infected individuals

Superior protection with 'mix-and-match' COVID-19 booster strategy

The neutralizing activity of a panel of 482 human monoclonal antibodies against Omicron BA.4 and BA.5

Study reveals key similarities between the nervous system of two early-diverging animal lineages

Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster

CDC study describes safety profile of second mRNA COVID booster

Cross-reactive SARS-CoV-2 antibodies after exposure to avian coronavirus vaccine

Study shows SARS-CoV-2 impairs interferon production through NSP2-induced repression of mRNA translation

The neutralizing antibody response in mRNA vaccinated and boosted healthcare workers against major circulating SARS-CoV-2 Omicron subvariants

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

Booster vaccination counters the severity of Omicron breakthrough infections

The clinical, epidemiological, and evolutionary consequences of a potential SARS-CoV-2-related bat virus spillover into humans

COVID-19 vaccine-boosted neutralizing antibody levels decrease substantially within 3 months

The known and proposed interactions of SARS-CoV and SARS-CoV-2 with DNA damage response pathways

Immunoglobulin G isotypes switch class following repeated SARS-CoV-2 mRNA vaccination

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News